Eli Lilly & Co. reports Q2 2025 results before the U.S. market opens on August 7. Analysts expect revenue of approximately ...

Eli Lilly (LLY) reports Q2 earnings on Aug 7, with booming diabetes and weight-loss drug sales driving strong growth.

In this strange new world where a weekly injection can quickly achieve what years of attempted diets may fail to do, the ...

Influencer Tana Mongeau has warned against taking the weight loss drug Mounjaro after she experienced severe side effects.

On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...

When Eli Lilly reports its financial results early Thursday, investors will be looking for the company to press its advantage ...

This podcast was recorded on July 21, 2025. Tim Beyers: Is it time to buy biotech? You're listening to Motley Fool Money.

The telehealth and wellness stock tanked more than 12% Aug. 5, a day after posting mixed Q2 earnings. More importantly, Bank ...

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...

The health and beauty firm behind the Myprotein brand has said its profits will fall by £13m because of the high price of key ...

Wegovy and Zepbound - except the weight regain is worse, because of the extreme way in which these medications suppress your ...